Aggressive blood pressure (BP) control is not associated with lower risk in cognitive decline, dementia, or mild cognitive impairment (MCI) compared to standard BP treatment.
Why this matters
Cerebrovascular disease (CVD) is a major risk factor for the development of neurodegenerative conditions, such as dementia, with high BP being an important risk factor for CVD.
In 2019, the World Health Organization guidelines recommended that adults with hypertension should receive standard hypertension management to reduce the risk of cognitive decline and/or dementia.
It is uncertain whether lower BP targets can yield better benefit cognitive outcomes than standard BP treatment.